<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Optometry Product Guide &#187; fluocinolone acetonide intravitreal implant</title>
	<atom:link href="http://www.optometryproductguide.com/blog/tag/fluocinolone-acetonide-intravitreal-implant/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.optometryproductguide.com/blog</link>
	<description>A comprehensive guide to optometry products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 13:00:25 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>FDA: Retisert Can Cause Cataracts</title>
		<link>http://www.optometryproductguide.com/blog/2008/11/10/fda-retisert-can-cause-cataracts/</link>
		<comments>http://www.optometryproductguide.com/blog/2008/11/10/fda-retisert-can-cause-cataracts/#comments</comments>
		<pubDate>Mon, 10 Nov 2008 07:55:09 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Cataracts]]></category>
		<category><![CDATA[Bausch & Lomb]]></category>
		<category><![CDATA[cataract]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[fluocinolone acetonide intravitreal implant]]></category>
		<category><![CDATA[intraocular pressure]]></category>
		<category><![CDATA[Retisert]]></category>

		<guid isPermaLink="false">http://www.optometryproductguide.com/blog/2008/11/10/fda-retisert-can-cause-cataracts/</guid>
		<description><![CDATA[The U.S. food and Drug Administration has approved safety labeling revisions for Bausch &#38; Lomb, Inc.’s  Retisert (a fluocinolone acetonide intravitreal implant). The new labeling includes warnings based on the now available 3-year clinical reports. Use of the product can cause cataracts which require surgical removal in all phakic eyes within an average 3-year period. [...]]]></description>
			<content:encoded><![CDATA[<p><img src="http://www.optometryproductguide.com/blog/wp-content/uploads/2008/11/bauschlomb.png" align="left" height="55" hspace="5" vspace="5" width="200" />The U.S. food and Drug Administration has approved safety labeling revisions for <a href="http://www.bausch.com/en_US/default.aspx">Bausch &amp; Lomb</a>, Inc.’s  Retisert (a fluocinolone acetonide intravitreal implant). The new labeling includes warnings based on the now available 3-year clinical reports. Use of the product can cause cataracts which require surgical removal in all phakic eyes within an average 3-year period. About 77% of patients will need drugs to lower intraocular pressure (IOP) within this period, and around 37% of patients may require filtering procedures for controlling elevated IOP.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.optometryproductguide.com/blog/2008/11/10/fda-retisert-can-cause-cataracts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
